tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

VERA Stock Latest News

Vera Therapeutics Holds 2025 Annual Stockholder Meeting
Company AnnouncementsVera Therapeutics Holds 2025 Annual Stockholder Meeting
22h ago
8K
VERA
Vera Therapeutics price target lowered to $55 from $60 at Scotiabank
PremiumThe Fly
Vera Therapeutics price target lowered to $55 from $60 at Scotiabank
8d ago
VERA
Vera Therapeutics: Strategic Advancements and Strong Financial Position Underpin Buy Rating
PremiumRatings
Vera Therapeutics: Strategic Advancements and Strong Financial Position Underpin Buy Rating
13d ago
VERA
Vera Therapeutics price target lowered to $26 from $34 at Wedbush
PremiumThe Fly
Vera Therapeutics price target lowered to $26 from $34 at Wedbush
13d ago
VERA
Vera Therapeutics Advances Atacicept in Key Trials
PremiumCompany Announcements
Vera Therapeutics Advances Atacicept in Key Trials
14d ago
VERA
Vera Therapeutics: Strong Financials and Promising Clinical Developments Support Buy Rating
PremiumRatingsVera Therapeutics: Strong Financials and Promising Clinical Developments Support Buy Rating
14d ago
VERA
Vera Therapeutics reports Q1 EPS (81c), consensus (78c)
Premium
The Fly
Vera Therapeutics reports Q1 EPS (81c), consensus (78c)
14d ago
VERA
Vera Therapeutics assumed with a Buy at H.C. Wainwright
Premium
The Fly
Vera Therapeutics assumed with a Buy at H.C. Wainwright
15d ago
VERA
Positive Outlook for Vera Therapeutics: Buy Rating on Atacicept’s Potential in IgA Nephropathy
PremiumRatings
Positive Outlook for Vera Therapeutics: Buy Rating on Atacicept’s Potential in IgA Nephropathy
2M ago
VERA
Vera Therapeutics completes enrollment in ORIGIN Phase 3 trial for atacicept
PremiumThe Fly
Vera Therapeutics completes enrollment in ORIGIN Phase 3 trial for atacicept
2M ago
VERA
3 Best Stocks to Buy Now, 3/27/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 3/27/2025, According to Top Analysts
2M ago
BRZE
PARR
Vera Therapeutics, Inc. (VERA) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Vera Therapeutics, Inc. (VERA) Q4 Earnings Cheat Sheet
2M ago
VERA
Vera Therapeutics price target lowered to $71 from $77 at JPMorgan
PremiumThe FlyVera Therapeutics price target lowered to $71 from $77 at JPMorgan
3M ago
VERA
Vera Therapeutics price target raised to $61 from $59 at Guggenheim
Premium
The Fly
Vera Therapeutics price target raised to $61 from $59 at Guggenheim
3M ago
VERA
Optimistic Buy Rating for Vera Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
Premium
Ratings
Optimistic Buy Rating for Vera Therapeutics: Strong Financials and Promising Pipeline Drive Positive Outlook
3M ago
VERA
Vera Therapeutics selloff a buying opportunity, says Evercore ISI
PremiumThe Fly
Vera Therapeutics selloff a buying opportunity, says Evercore ISI
3M ago
VERA
Buy Rating for Vera Therapeutics: Atacicept’s Unique Potential in the IgAN Market
PremiumRatings
Buy Rating for Vera Therapeutics: Atacicept’s Unique Potential in the IgAN Market
3M ago
VERA
Vera Therapeutics pullback a buying opportunity, says Cantor Fitzgerald
PremiumThe Fly
Vera Therapeutics pullback a buying opportunity, says Cantor Fitzgerald
3M ago
VERA
Vera Therapeutics’ Atacicept Positioned for Growth Amid Market Overreaction to Otsuka’s Sibeprenlimab
PremiumRatings
Vera Therapeutics’ Atacicept Positioned for Growth Amid Market Overreaction to Otsuka’s Sibeprenlimab
3M ago
VERA
Vera Therapeutics selloff Friday overblown, says JPMorgan
PremiumThe FlyVera Therapeutics selloff Friday overblown, says JPMorgan
3M ago
VERA
3 Best Stocks to Buy Now, 2/18/2025, According to Top Analysts
Premium
Market News
3 Best Stocks to Buy Now, 2/18/2025, According to Top Analysts
3M ago
HL
RARE
Buy Rating Affirmed for Vera Therapeutics Amid Promising Atacicept Prospects and Market Overreaction Concerns
Premium
Ratings
Buy Rating Affirmed for Vera Therapeutics Amid Promising Atacicept Prospects and Market Overreaction Concerns
3M ago
VERA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >